Frontiers in Pharmacology (Oct 2022)

Research progress on microRNA in gout

  • Jing Xie,
  • Cuixia He,
  • Cuixia He,
  • Yue Su,
  • Yue Su,
  • Yuzhou Ding,
  • Xingyu Zhu,
  • Xingyu Zhu,
  • Yuanyuan Xu,
  • Yuanyuan Xu,
  • Jiaxiang Ding,
  • Jiaxiang Ding,
  • Huan Zhou,
  • Huan Zhou,
  • Huan Zhou,
  • Hongju Wang

DOI
https://doi.org/10.3389/fphar.2022.981799
Journal volume & issue
Vol. 13

Abstract

Read online

Gout is a common form of arthritis caused by the deposition of sodium urate crystals in the joints and tissues around them. MicroRNAs (miRNAs) are noncoding RNAs that have been shown to be involved in regulating the pathogenesis of gout through multiple cellular signaling pathways, which may be potential targets for the treatment of gout. In this review, we systematically discuss the regulatory roles of related miRNAs in gout, which will provide help for the treatment of gout and miRNAs is expected to become a potential biomarker for gout diagnosis.

Keywords